Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand
Consumers suffering from flu, cold and allergy symptoms tend to have a number of ailments when they are sick; therefore, understandably, one product that targets a range of problems, such as fever, headache, blocked sinuses, cough and sore throat, tends to be the preferred option by many consumers. Therefore, combination products saw the strongest current value growth in 2017. Products containing pseudoephedrine as an active ingredient were reclassified in New Zealand from September 2011 from ph...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.